Evaluating Quinacrine as a Potential Amyloid Imaging Compound: Studies on Hen Egg White Lysozyme as Model System

Author(s): Manjeet Kumar, Nandini Sarkar, Vikash Kumar Dubey

Journal Name: Protein & Peptide Letters

Volume 19 , Issue 8 , 2012

Become EABM
Become Reviewer
Call for Editor


Amyloid plaque is associated with several neuronal and non-neuronal degenerative diseases. More than twenty human proteins can fold abnormally to form pathological deposits like amyloid plaque. Strategies for treating such diseases include therapies designed to decrease protein plaque formation or its complete clearance, but monitoring/clinical trials of these treatments are limited by the lack of effective methods to monitor amyloid deposits in the organs/tissues of living patients. The current study shows binding and staining ability of quinacrine to protein amyloid deposits, using Hen Egg White Lysozyme (HEWL) as model system and characterization of its binding interaction with HEWL, employing several biophysical techniques. Since quinacrine can pass the blood brain barrier, the current report suggests potential application of quinacrine for antemortem diagnostic of amyloid.

Keywords: Amyloid plaque, fluorescence quenching, FTIR, hen egg white lysozyme, imaging, quinacrine, fibrillar protein, Alzheimer’s disease, Parkinson’s Disease, Type II Diabetes Mellitus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 03 July, 2012
Page: [826 - 831]
Pages: 6
DOI: 10.2174/092986612801619598
Price: $65

Article Metrics

PDF: 6